Systemic sclerosis. Introduction, Autoimmun Rev, vol.10, pp.239-279, 2011. ,
Criteria for the classification of early systemic sclerosis, J Rheumatol, vol.28, pp.1573-1579, 2001. ,
Systemic sclerosis: an update in 2016, Autoimmun Rev, vol.15, pp.417-443, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01297570
Mapping and predicting mortality from systemic sclerosis, Ann Rheum Dis, vol.76, pp.1897-905, 2017. ,
Determinants of mortality in systemic sclerosis: a focused review, Rheumatol Int, vol.38, pp.1847-58, 2017. ,
Systemic sclerosis and malignancy: a review of current data, J Clin Med Res, vol.8, pp.625-657, 2016. ,
Safety, tolerability and potential efficacy of injection of autologous adiposederived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial, Ann Rheum Dis, vol.74, pp.2175-82, 2015. ,
Fibroblast precursors in normal and irradiated mouse hematopoietic organs, Exp Hematol, vol.4, pp.267-74, 1976. ,
Mesenchymal stem cells reside in virtually all post-natal organs and tissues, J Cell Sci, vol.119, pp.2204-2217, 2006. ,
Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo, Cell Stem Cell, vol.20, pp.345-59, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01785316
Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement, Cytotherapy, vol.8, pp.315-322, 2006. ,
Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes, Biochimie, vol.95, pp.2229-2263, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00832507
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway, PLoS ONE, vol.7, p.45272, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00758222
Mesenchymal stem cells on horizon: a new arsenal of therapeutic agents, Stem Cell Rev, vol.14, pp.484-99, 2018. ,
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cells, vol.24, pp.1294-301, 2006. ,
Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation, Cell Transplant, vol.16, pp.555-62, 2007. ,
Therapeutic application of mesenchymal stem cells in osteoarthritis, Expert Opin Biol Ther, vol.16, pp.33-42, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01834251
mesenchymal stem cell therapy for ischemic stroke, Acta Med Okayama, vol.71, pp.263-271, 2017. ,
Update on mesenchymal stem cell-based therapy in lupus and scleroderma, Arthritis Res Ther, vol.17, p.301, 2015. ,
Stem cell therapy for ischemic heart diseases, Br Med Bull, vol.121, pp.135-54, 2017. ,
Adipose tissue as a strategic source of mesenchymal stem cells in bone regeneration: a topical review on the most promising craniomaxillofacial applications, Int J Mol Sci, vol.18, p.2140, 2017. ,
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials, PLoS ONE, vol.7, p.47559, 2012. ,
Animal models of systemic sclerosis: their utility and limitations, Open Access Rheumatol, vol.6, pp.65-81, 2014. ,
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?, Int J Biochem Cell Biol, vol.40, pp.362-82, 2008. ,
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects, Proc Natl Acad Sci, vol.100, pp.8407-8418, 2003. ,
Bone marrowderived mesenchymal stem cells in repair of the injured lung, Am J Respir Cell Mol Biol, vol.33, pp.145-52, 2005. ,
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury, Eur Respir J, vol.34, pp.740-748, 2009. ,
Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats, Transplant Proc, vol.40, pp.1700-1705, 2008. ,
Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis, Respir Res, vol.11, p.16, 2010. ,
Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice, Int Wound J, vol.11, pp.701-711, 2014. ,
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury, Am J Pathol, vol.175, pp.303-316, 2009. ,
Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis, Cell Transplant, vol.18, pp.405-427, 2009. ,
Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage, PLoS ONE, vol.8, 2013. ,
Antiinflammatory effects of adult stem cells in sustained lung injury: a comparative study, PLoS ONE, vol.8, p.69299, 2013. ,
The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice, Exp Lung Res, vol.40, pp.117-142, 2014. ,
Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat, Int J Stem Cells, vol.7, pp.33-42, 2014. ,
Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion, Cytotherapy, vol.18, pp.536-581, 2016. ,
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model, Osaka City Med J, vol.61, pp.81-91, 2015. ,
Inhibition of bleomycininduced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-gamma, and TGF-beta, Cell Biochem Funct, vol.33, pp.356-66, 2015. ,
Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis, Transl Res, vol.166, pp.554-67, 2015. ,
Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing, J Cell Physiol, vol.233, pp.5503-5515, 2018. ,
Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse, J Immunol, vol.182, pp.5855-64, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00517814
Anti-fibrotic, anti-oxidant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis, Arthritis Rheumatol, vol.68, pp.1013-1038, 2016. ,
Human adipose mesenchymal stem cells as potent antifibrosis therapy for systemic sclerosis, J Autoimmun, vol.70, pp.31-40, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01834289
, Arthritis Rheumatol, vol.68, pp.2348-50, 2016.
Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents, Lab Invest, vol.85, pp.1199-209, 2005. ,
Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis, Cell Res, vol.27, pp.559-77, 2017. ,
Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats, Mol Med Rep, vol.11, pp.1685-92, 2015. ,
Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis, Mol Med Rep, vol.11, pp.2831-2838, 2015. ,
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury, Proc Natl Acad Sci, vol.104, pp.11002-11009, 2007. ,
Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycininduced pulmonary fibrosis, Stem Cells Transl Med, vol.5, pp.1307-1325, 2016. ,
Oncostatin M-preconditioned mesenchymal stem cells alleviate bleomycin-induced pulmonary fibrosis through paracrine effects of the hepatocyte growth factor, Stem Cells Transl Med, vol.6, pp.1006-1023, 2017. ,
Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis, Stem Cell Res Ther, vol.6, p.97, 2015. ,
N-acetylcysteinepretreated human embryonic mesenchymal stem cell administration protects against bleomycin-induced lung injury, Am J Med Sci, vol.346, pp.113-135, 2013. ,
Modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model, Am J Physiol Lung Cell Mol Physiol, vol.313, pp.92-103, 2017. ,
Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury, Mol Med Rep, vol.11, pp.2387-96, 2015. ,
Bone Marrow-derived mesenchymal stem cells expressing thioredoxin 1 attenuate bleomycininduced skin fibrosis and oxidative stress in scleroderma, J Invest Dermatol, vol.137, pp.1223-1256, 2017. ,
Multilineage potential of adult human mesenchymal stem cells, Science, vol.284, pp.143-150, 1999. ,
Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis, Clin Rev Allergy Immunol, vol.52, pp.234-59, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01342436
Mesenchymal stromal cells based therapy in systemic sclerosis: rational and challenges, Front Immunol, vol.9, 2013. ,
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogeneic-stimulated lymphocytes in vitro, Rheumatology, vol.46, pp.403-411, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00479753
Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis, Ann Rheum Dis, vol.67, pp.443-452, 2008. ,
Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis, Cell Transplant, vol.22, pp.779-95, 2013. ,
Phenotypical and functional characteristics of "in vitro" expanded adipose-derived mesenchymal stromal cells from patients with systemic sclerosis, Cell Transplant, vol.26, pp.841-54, 2017. ,
Alterations of ROS pathways in scleroderma begin at stem cell level, J Biol Regul Homeost Agents, vol.27, pp.211-235, 2013. ,
Serum-mediated oxidative stress from systemic sclerosis patients affects mesenchymal stem cell function. Front Immunol, vol.8, p.988, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01623926
Expression of transforming growth factor beta receptor II in mesenchymal stem cells from systemic sclerosis patients, BMJ Open, vol.3, 2013. ,
Bone marrow endothelial progenitors are defective in systemic sclerosis, Arthritis Rheum, vol.54, pp.2605-2620, 2006. ,
Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine, Angiogenesis, vol.16, pp.595-607, 2013. ,
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy, Clin Exp Immunol, vol.173, pp.195-206, 2013. ,
Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features, Arthritis Res Ther, vol.16, p.442, 2014. ,
Intrinsic deregulation of vascular smooth muscle and myofibroblast differentiation in mesenchymal stromal cells from patients with systemic sclerosis, PLoS ONE, vol.11, 2016. ,
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro, Ann Rheum Dis, vol.70, pp.2011-2032, 2011. ,
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine, Stem Cell Res Ther, vol.8, p.23, 2017. ,
Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality, Plast Reconstr Surg, vol.133, pp.1109-1127, 2014. ,
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis, Cell Transplant, vol.24, pp.2297-305, 2015. ,
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients, Stem Cell Res Ther, vol.8, p.236, 2017. ,
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L, Leukemia, vol.22, pp.1062-1066, 2008. ,
Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases, Arthritis Rheum, vol.63, pp.2540-2542, 2011. ,
Improvement of mouth functional disability in systemic sclerosis patients over one year in a trial of fat transplantation versus adipose-derived stromal cells, Stem Cells Int, p.2416192, 2016. ,
State of the art. Autologous fat graft and adipose tissue-derived stromal vascular fraction injection for hand therapy in systemic sclerosis patients, Curr Res Transl Med, vol.64, pp.35-42, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01460050
A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol, Curr Res Transl Med, vol.65, p.20479, 2017. ,